- 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
- 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
- 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
- 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
- 如果EPS衰退，要觀察同業是不是有一樣的狀況
- 要留意增資減資和公司債對股本及EPS的影響
| 加權平均股數 QoQ YoY | EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | 營收 QoQ YoY | 毛利率(%) QoQ YoY | 營業利益率 QoQ YoY | 稅後淨利率 QoQ YoY | 營業利益 QoQ YoY | 稅後淨利 QoQ YoY | 稅前淨利率(%) QoQ YoY | 稅後淨利率(%) QoQ YoY | 兩季平均(YOY)營收成長率(%) | 兩季平均(YOY)EPS成長率(%) | 兩季平均(YOY)本業EPS成長率(%) | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 129 | 0.0 | 13.16 | -0.70 | -55.56 | -134.48 | -0.71 | -29.09 | -141.52 | -1.60 | -77.78 | -279.78 | 0.41 | 310.0 | -86.98 | 26.14 | -8.28 | -73.86 | -225.19 | 69.75 | -420.65 | -220.16 | 64.16 | -400.19 | -0.92 | -29.58 | -141.63 | -0.9 | -52.54 | -138.96 | -220.16 | 64.16 | -400.19 | -220.16 | 64.16 | -400.19 | 155.00 | -27.78 | -15.47 |
| 24Q2 (19) | 129 | 8.4 | 16.22 | -0.45 | 0.0 | 26.23 | -0.55 | -1.85 | -3.77 | -0.90 | -100.0 | 23.73 | 0.1 | 0 | 0 | 28.50 | 113.8 | 0 | -744.34 | 99.2 | 0 | -614.22 | 99.13 | 0 | -0.71 | -1.43 | -1.43 | -0.59 | -11.32 | 11.94 | -614.22 | 99.13 | 0 | -614.22 | 99.13 | 0 | 0.00 | 22.22 | 10.50 |
| 24Q1 (18) | 119 | 5.31 | 7.21 | -0.45 | 44.44 | 21.05 | -0.54 | 22.86 | -8.0 | -0.45 | -742.86 | 21.05 | 0 | 0 | 0 | 13.33 | 0 | 0 | -92924.00 | 0 | 0 | -70560.00 | 0 | 0 | -0.7 | 22.22 | -9.38 | -0.53 | 41.76 | 17.19 | -70560.00 | 0 | 0 | -70560.00 | 0 | 0 | -50.00 | -47.73 | -59.04 |
| 23Q4 (17) | 113 | -0.88 | 14.14 | -0.81 | -139.9 | -76.09 | -0.70 | -140.94 | -94.44 | 0.07 | -92.13 | 102.59 | 0 | -100.0 | 0 | 0.00 | -100.0 | 0 | 0.00 | -100.0 | 0 | 0.00 | -100.0 | 0 | -0.9 | -140.72 | -91.49 | -0.91 | -139.39 | -102.22 | 0.00 | -100.0 | 0 | 0.00 | -100.0 | 0 | -50.00 | 146.44 | 140.85 |
| 23Q3 (16) | 114 | 2.7 | 16.33 | 2.03 | 432.79 | 422.22 | 1.71 | 422.64 | 442.0 | 0.89 | 175.42 | 139.38 | 3.15 | 0 | 0 | 100.00 | 0 | 0 | 70.23 | 0 | 0 | 73.34 | 0 | 0 | 2.21 | 415.71 | 440.0 | 2.31 | 444.78 | 472.58 | 73.34 | 0 | 0 | 73.34 | 0 | 0 | 0.00 | 212.89 | 208.32 |
| 23Q2 (15) | 111 | 0.0 | 13.27 | -0.61 | -7.02 | 62.58 | -0.53 | -6.0 | 56.91 | -1.18 | -107.02 | 27.61 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | -0.7 | -9.38 | 56.25 | -0.67 | -4.69 | 57.86 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | -15.46 | -22.45 |
| 23Q1 (14) | 111 | 12.12 | 0 | -0.57 | -23.91 | 0 | -0.50 | -38.89 | 0 | -0.57 | 78.89 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | -0.64 | -36.17 | 0 | -0.64 | -42.22 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 1.54 | -5.45 |
| 22Q4 (13) | 99 | 1.02 | 16.47 | -0.46 | 26.98 | 74.16 | -0.36 | 28.0 | 69.75 | -2.70 | -19.47 | 10.6 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | -0.47 | 27.69 | 69.28 | -0.45 | 27.42 | 70.2 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 44.16 | 43.67 |
| 22Q3 (12) | 98 | 0.0 | 0 | -0.63 | 61.35 | 0 | -0.50 | 59.35 | 0 | -2.26 | -38.65 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | -0.65 | 59.38 | 0 | -0.62 | 61.01 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 30.68 | 29.68 |
| 22Q2 (11) | 98 | 0 | 20.99 | -1.63 | 0 | -24.43 | -1.23 | 0 | -51.85 | -1.63 | 0 | -24.43 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | -1.6 | 0 | -50.94 | -1.59 | 0 | -51.43 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 50.00 | 50.00 |
| 22Q1 (10) | 0 | -100.0 | 0 | 0.00 | 100.0 | 0 | 0.00 | 100.0 | 0 | 0.00 | 100.0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | 0 | 100.0 | 0 | 0 | 100.0 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 50.00 | 50.00 |
| 21Q4 (9) | 85 | 0 | 0 | -1.78 | 0 | 0 | -1.19 | 0 | 0 | -3.02 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | -1.53 | 0 | 0 | -1.51 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 50.00 | 50.00 |
| 21Q3 (8) | 0 | -100.0 | 0 | 0.00 | 100.0 | 0 | 0.00 | 100.0 | 0 | 0.00 | 100.0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | 0 | 100.0 | 0 | 0 | 100.0 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 50.00 | 50.00 |
| 21Q2 (7) | 81 | 0 | 0 | -1.31 | 0 | 0 | -0.81 | 0 | 0 | -1.31 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | -1.06 | 0 | 0 | -1.05 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/11 | 0.0 | -100.0 | 0.0 | 1.63 | -48.12 | 1.54 | N/A | 本年累計較去年同期減少，係因前期認列授權簽約金收入較高所致。 | ||
| 2024/10 | 1.13 | 175.35 | 0.0 | 1.63 | -48.12 | 1.54 | N/A | 本月營收較去年同期增加，係因本月認列授權簽約金收入；本年累計較去年同期減少，係因前期認列授權簽約金收入較高所致。 | ||
| 2024/9 | 0.41 | 0.0 | 0.0 | 0.51 | -83.93 | 0.41 | 0.46 | 本月營收較去年同期增加，係因本月認列銷貨收入；本年累計較去年同期減少，係因前期認列授權簽約金收入。 | ||
| 2024/8 | 0.0 | 0.0 | 0.0 | 0.1 | -96.94 | 0.0 | 0 | 去年係因認列授權簽約金收入。 | ||
| 2024/7 | 0.0 | 0.0 | -100.0 | 0.1 | -96.94 | 0.1 | 1.99 | 去年同期係因認列授權簽約金收入。 | ||
| 2024/6 | 0.0 | -100.0 | 0.0 | 0.1 | 0.0 | 0.1 | 3.77 | 銷售L606研發用藥及保健食品 | ||
| 2024/5 | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 3.77 | 銷售L606研發用藥 | ||
| 2024/4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | N/A | 銷售保健食品之營收 | ||
| 2024/3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | N/A | 銷售保健食品之營收 | ||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A |
| 加權平均股數 YoY | EPS YoY | 本業EPS YoY | 營收 YoY | 毛利率(%) YoY | 營業利益率 YoY | 稅後淨利率 YoY | 營業利益 YoY | 稅前淨利 YoY | 稅後淨利 YoY | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 113 | 14.14 | 0.07 | 0 | -0.02 | 0 | 3.15 | 0 | 100.00 | 0 | -0.90 | 0 | 2.69 | 0 | -0.03 | 0 | 0.08 | 0 | 0.08 | 0 |
| 2022 (9) | 99 | 16.47 | -2.70 | 0 | -2.11 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | -2.72 | 0 | -2.67 | 0 | -2.67 | 0 |
| 2021 (8) | 85 | 77.08 | -3.02 | 0 | -2.01 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | -2.59 | 0 | -2.56 | 0 | -2.56 | 0 |
| 2020 (7) | 48 | 29.73 | -3.82 | 0 | -1.46 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | -1.87 | 0 | -1.82 | 0 | -1.82 | 0 |
| 2019 (6) | 37 | 146.67 | -3.48 | 0 | -1.09 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | -1.39 | 0 | -1.3 | 0 | -1.3 | 0 |
| 2018 (5) | 15 | 0 | 0.00 | 0 | -0.64 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | -0.82 | 0 | -0.8 | 0 | -0.8 | 0 |
